1. Home
  2. INSG vs MOLN Comparison

INSG vs MOLN Comparison

Compare INSG & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$11.40

Market Cap

174.9M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.09

Market Cap

151.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
MOLN
Founded
1996
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
174.9M
151.2M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
INSG
MOLN
Price
$11.40
$4.09
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$15.33
$3.75
AVG Volume (30 Days)
167.7K
4.3K
Earning Date
02-19-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$165,876,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.34
$999.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.24
$3.36
52 Week High
$18.11
$5.41

Technical Indicators

Market Signals
Indicator
INSG
MOLN
Relative Strength Index (RSI) 52.73 46.14
Support Level $11.49 $3.97
Resistance Level $12.71 $4.28
Average True Range (ATR) 0.68 0.15
MACD 0.19 -0.02
Stochastic Oscillator 55.38 26.22

Price Performance

Historical Comparison
INSG
MOLN

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: